2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 |
|
2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 ±³À°ÁÖÁ¦ : 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ ´ã´çÀÚ : ±èÇýÁø À̸ÞÀÏ : hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú Âü¼®¿¹»óÀÎ : 60¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 50,000¿ø ºñ°í ºñȸ¿ø 50,000¿ø
±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 14:10~14:50 WFH 2024 highlight 1: Recent progress in the treatment strategy of hemophilia ÇÑÁ¤¿ì(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 14:50~15:30 WFH 2024 highlight 2: Hemostasis laboratory in the era of non-replacement therapy ÃÖ¿µ¹è(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 15:30~16:10 Exploring personalized tailored hemophilia treatment ¹ÚÁ¤¾Æ(ÀÎÇÏÀÇ´ë) ±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 16:30~17:00 Coil Embolization of Unruptured Dissecting Aneurysm in Vertebral Artery of Hemophilia Patient ¹ÚÁö°æ(ÀÎÁ¦ÀÇ´ë) ±³À°½Ã°£ 05¿ù 24ÀÏ ¿ÀµðÅ丮¿ò 17:00~17:30 Pediatric VWD(Von Willebrand disease) patients with recombinant VWF(Von Willebrand disease) concentrates ¹Ú¿µ½Ç(°æÈñÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|